After discovering the pivotal role of DLAT in BC, Sha et al. constructed a risk score model for HER 2+ BC patients based on CRGs, and confirmed DLAT as an independent prognostic factor for HER2+ BC patients in further analysis 53. The gene discussed is ERBB2; the disease is breast cancer.